Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer
Cancer · 2025
DOI: 10.1002/cncr.35879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Naveen Manisundaram und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Black or African American, Gastrointestinal Neoplasms, Healthcare Disparities, Medicaid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Racial minority groups experience disparities in cancer treatment and mortality. This study aimed to investigate the effect of Medicaid expansion on the existing racial disparities in all‐cause mortality among patients with gastrointestinal malignancies.
Methods
A cross‐sectional cohort study of patients with pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), and gastric adenocarcinoma (GC) of any stage was conducted using data from the National Cancer Database (2009–2019). Using difference‐in‐difference (DID) analysis, the authors compared adjusted 2‐year mortality rates among Black and White patients residing in states with expanded Medicaid benefits (MES) and non‐MES before (2009–2013) and after (2014–2019) Medicaid expansion.
Results
A total of 86,052 patients were included in this analysis, including 19,188 patients with PDAC, 60,404 with CRC, and 6460 with GC. Two‐year mortality rates decreased among Black patients with PDAC residing in MES but not those residing in non‐MES following Medicaid expansion (DID, –9.4%; 95% confidence interval [CI], –14.4% to –4.4%; p < .001). Mortality decreased more among Black and White patients with CRC in MES compared to those in non‐MES following Medicaid expansion (DID, –2.9%; 95% CI, –5.7 to –0.04; p = .047 and DID, –4.2%; 95% CI, –5.8 to –2.5; p < .001, respectively). Black patients with GC in MES experienced a marked reduction in mortality compared to those in non‐MES (DID, –7.7%, 95% CI, –16.1 to 0.56; p = .07).
Conclusion
Medicaid expansion was associated with a greater reduction in 2‐year mortality rates among Black patients residing in MES compared to those residing in non‐MES. Existing racial disparities in mortality remained the same or worsened in non‐MES but were mitigated in MES following Medicaid expansion in almost all comparisons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Surgery, Albany Medical Center, Albany, New York, USA.
ORCID-Profile: Naveen Manisundaram, Rebecca A Snyder, Joshua N Herb
Förderung
- NCI NIH HHS
Zitieren
APA
Manisundaram, N., Snyder, R. A., Hu, C. Y., DiBrito, S. R., Herb, J. N., & Chang, G. J. (2025). Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer. Cancer. https://doi.org/10.1002/cncr.35879
Vancouver
Manisundaram N, Snyder RA, Hu CY, DiBrito SR, Herb JN, Chang GJ. Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer. Cancer. 2025. doi:10.1002/cncr.35879
BibTeX
@article{Manisundaram2025,
author = {Manisundaram, Naveen and Snyder, Rebecca A and Hu, Chung-Yuan and DiBrito, Sandra R and Herb, Joshua N and Chang, George J},
title = {Impact of Medicaid expansion on racial disparities among patients with gastrointestinal cancer},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35879}
}
EUVIMED